Finance

Lists
RVTY:NYSE
Revvity Inc
၁၅၁.၅၃ US$
+၁.၆၆%
(+၂.၄၇) 1D
၁၅၁.၅၃ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၂, GMT-၄ ၁၆:၀၂:၃၉  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RVTY...
Open
၁၄၉.၉၄ US$
High
၁၅၃.၃၈ US$
Low
၁၄၈.၅၅ US$
Mkt. cap
ဋေ ၁.၆၉ ထ
Avg. vol.
၂.၁၄ သန်း
Volume
၁.၂၄ သန်း
52-wk high
၁၅၈.၂၈ US$
52-wk low
၈၁.၂၂ US$
Beta
၁.၀၆
Shares outstanding
၁၁.၁၆ ကုဋေ
No. of employees
၁ သောင်း
Open
၁၄၉.၉၄ US$
High
၁၅၃.၃၈ US$
Low
၁၄၈.၅၅ US$
Mkt. cap
ဋေ ၁.၆၉ ထ
Avg. vol.
၂.၁၄ သန်း
Volume
၁.၂၄ သန်း
52-wk high
၁၅၈.၂၈ US$
52-wk low
၈၁.၂၂ US$
Beta
၁.၀၆
Shares outstanding
၁၁.၁၆ ကုဋေ
No. of employees
၁ သောင်း
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
ပြီးခဲ့သည့် ၂၃ နာရီ
Discipline and Rules-Based Execution in RVTY Response
Zacks
Zacks
·
ပြီးခဲ့သည့် ၂ ရက်
Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?
Profile
Revvity, Inc. is a multinational company headquartered in Waltham, Massachusetts, USA, in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY. Wikipedia
About Revvity Inc
CEOPrahlad Singh
Employees၁.၁ သောင်း
Founded၁၉၄၇
HeadquartersWaltham, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 13 analysts giving stock ratings to RVTY in the past 3 months
Buy
Buy
4
Hold
9
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for RVTY in the last 3 months.
Highest
Current ၁၅၁.၅၃ US$
၁၆၅.၀၀ US$ (+၈.၈၉%)
Average
၁၂၇.၃၆ US$ (-၁၅.၉၅%)
Lowest
၁၁၀.၀၀ US$ (-၂၇.၄၁%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eve Burstein
Bernstein
Hold
Maintained
၁၂၀.၀၀ US$
-၂၀.၈%
09/25/2026
Evie Koslosky
Goldman Sachs
Hold
Maintained
၁၄၀.၀၀ US$
-၇.၆%
09/20/2026
Unknown Analyst
CFRA
Hold
Downgraded
-
-
09/18/2026
Unknown Analyst
UBS
Hold
Initiated
၁၄၀.၀၀ US$
-၇.၆%
09/08/2026
Doug Schenkel
UBS
Hold
Downgraded
၁၄၀.၀၀ US$
-၇.၆%
09/09/2026
Paul Knight
KeyBanc
Buy
Maintained
၁၆၅.၀၀ US$
+၈.၉%
09/04/2026
Unknown Analyst
KeyBanc
Buy
Maintained
၁၆၅.၀၀ US$
+၈.၉%
09/04/2026
Dan Leonard
RBC Capital
Hold
Initiated
၁၃၅.၀၀ US$
-၁၀.၉%
09/01/2026
Casey Woodring
J.P. Morgan
Hold
Maintained
၁၁၀.၀၀ US$
-၂၇.၄%
08/06/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
၁၂၆.၀၀ US$
-၁၆.၈%
08/05/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
၁၁၀.၀၀ US$
-၂၇.၄%
08/05/2026
Daniel Arias
Stifel Nicolaus
Hold
Reiterated
၁၁၀.၀၀ US$
-၂၇.၄%
08/05/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
၁၃၀.၀၀ US$
-၁၄.၂%
08/07/2026
Luke Sergott
Barclays
Hold
Maintained
၁၁၅.၀၀ US$
-၂၄.၁%
08/04/2026
Puneet Souda
Leerink Partners
Buy
Reiterated
-
-
07/17/2026
Michael Polark
Wolfe Research
Hold
Initiated
-
-
06/01/2026
Michael Ryskin
Bank of America Securities
Hold
Maintained
-
-
05/14/2026
Unknown Analyst
Guggenheim
Hold
Reiterated
-
-
05/11/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
၁၁၇.၀၀ US$
-၂၂.၈%
05/04/2026
Unknown Analyst
Goldman Sachs
Hold
Maintained
၉၅.၀၀ US$
-၃၇.၃%
04/14/2026
Jack Meehan
Nephron
Hold
Upgraded
၉၀.၀၀ US$
-၄၀.၆%
03/26/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
၁၁၀.၀၀ US$
-၂၇.၄%
02/03/2026
Tycho Peterson
Jefferies
Hold
Maintained
၁၀၅.၀၀ US$
-၃၀.၇%
02/02/2026
Last report
၂၀၂၆ ဩ ၄
Fiscal period
Q2 2026
EPS / Est. (USD)
၁.၄၁ US$ / ၁.၂၂ US$
+၁၅.၉၃%beat
Revenue / Est. (USD)
၇၂.၉၇ ကုဋေ / ၇၀.၃၀ ကုဋေ
+၃.၈၀%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ ဧ
၂၀၂၆ ဇူ
Revenue
၆၉.၈၉ ကုဋေ
၇၇.၂၁ ကုဋေ
၇၁.၁၁ ကုဋေ
၇၂.၉၇ ကုဋေ
Cost of goods sold
၃၂.၄၃ ကုဋေ
၃၅.၀၄ ကုဋေ
၃၂.၃၅ ကုဋေ
၃၁.၂၈ ကုဋေ
Cost of revenue
၃၂.၄၃ ကုဋေ
၃၅.၀၄ ကုဋေ
၃၂.၃၅ ကုဋေ
၃၁.၂၈ ကုဋေ
Research and development expenses
၅.၀၈ ကုဋေ
၅.၈၂ ကုဋေ
၅.၇၉ ကုဋေ
၄.၉၀ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၂.၇၄ ကုဋေ
၂၀.၈၆ ကုဋေ
၂၄.၁၉ ကုဋေ
၂၄.၃၅ ကုဋေ
Operating expense
၂၇.၈၂ ကုဋေ
၂၆.၆၇ ကုဋေ
၂၉.၉၈ ကုဋေ
၂၉.၂၄ ကုဋေ
Total operating expenses
၆၀.၂၆ ကုဋေ
၆၁.၇၁ ကုဋေ
၆၂.၃၃ ကုဋေ
၆၀.၅၃ ကုဋေ
Operating income
၉.၆၄ ကုဋေ
၁၅.၄၉ ကုဋေ
၈.၇၉ ကုဋေ
၁၂.၄၄ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
၅.၅၇ ကုဋေ
၉.၁၆ ကုဋေ
၅.၀၀ ကုဋေ
၆.၃၅ ကုဋေ
EBT excluding unusual items
၇.၆၅ ကုဋေ
၁၃.၃၄ ကုဋေ
၆.၅၉ ကုဋေ
၁၀.၅၄ ကုဋေ
Income tax expense
၈.၄၆ သန်း
-၄.၂၁ သန်း
၉.၁၀ သန်း
၁.၀၀ ကုဋေ
Effective tax rate
၁၅.၂၀%
-၄.၆၀%
၁၈.၂၀%
၁၅.၈၂%
Other operating expenses
-
-
-
-
Net income
၄.၆၇ ကုဋေ
၉.၈၄ ကုဋေ
၄.၀၇ ကုဋေ
၅.၁၈ ကုဋေ
Net profit margin
၆.၆၇%
၁၂.၇၄%
၅.၇၃%
၇.၁၀%
Earnings per share
၁.၁၈
၁.၇၀
၁.၀၆
၁.၄၁
Interest and investment income
၆.၉၂ သန်း
၅.၇၅ သန်း
၆.၃၀ သန်း
၅.၂၆ သန်း
Interest expense
-၂.၂၈ ကုဋေ
-၂.၃၅ ကုဋေ
-၂.၄၇ ကုဋေ
-၂.၃၀ ကုဋေ
Net interest expenses
-၁.၅၈ ကုဋေ
-၁.၇၈ ကုဋေ
-၁.၈၄ ကုဋေ
-၁.၇၇ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၁၉.၈၄ ကုဋေ
၂၅.၈၀ ကုဋေ
၁၉.၂၉ ကုဋေ
၂၂.၆၅ ကုဋေ
Gain or loss from assets sale
-
-
-၅.၀၇ သန်း
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ